Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Sept 2023 for Paratek Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Rolf K. Hoffmann: trading record in brief
Rolf K. Hoffmann (board member) discloses dealings in Paratek Pharmaceuticals, Inc. to SEC (Form 4). Between 16 February 2022 and 21 September 2023, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 21 September 2023 with a transaction in Paratek Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rolf K. Hoffmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
64,000 sharesCommon StockSEC:0000899243-23-019367:0
20,000 shares0Common StockSEC:0000904454-23-000105:0
20,000 shares0Common StockSEC:0000904454-22-000167:0
3 of 3 declarations
